Brand dynamics

Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health

Lizhu Reagent's monkeypox virus detection product obtains CE certification

Published Time:

2022-06-10

 
According to a WHO announcement on June 8th, over 1000 confirmed cases of monkeypox have been reported to the WHO from 29 non-endemic countries and regions in just one month (May 13th to June 8th). Since the UK reported the first confirmed case of monkeypox in early May, the virus has spread rapidly in non-endemic countries and regions, with Europe being the hardest hit.

In response to the sudden global outbreak of monkeypox, Lizhu Reagents quickly responded and actively developed a monkeypox virus nucleic acid detection kit (PCR-fluorescence probe method), which has obtained EU CE approval.

 

The monkeypox virus nucleic acid detection kit (PCR-fluorescence probe method) is based on real-time fluorescence quantitative PCR technology and can qualitatively detect monkeypox virus nucleic acid in samples based on changes in fluorescence signals.

 

 

This product can be sold in the 27 member states of the European Union and countries and regions that recognize EU CE qualifications, providing a basis for the prevention and control and diagnosis and treatment of monkeypox virus infection.
The rapid development of this monkeypox virus nucleic acid detection kit is based on Lizhu Reagents' mature R&D capabilities. The launch of this product further enriches the company's product matrix and will accelerate the company's overseas market development. Lizhu Reagents not only focuses on the domestic market but is also committed to promoting "Chinese innovation" to the world. We will continue to innovate and develop with craftsmanship to contribute to global public health prevention and control.
​
Source: Lizhu Reagents Official